Sonia Vallet
Krems An Der Donau, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Effectiveness, toxicity and treatment adjustments of lenvatinib plus pembrolizumab in advanced renal cell carcinoma: a multicenter real-world analysis.
Journal: ESMO real world data and digital oncology
Published: February 06, 2026
The janus-faced effect of PD1 signaling on bone: do sex and age matter?
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Published: May 22, 2025
Enfortumab vedotin plus pembrolizumab in treatment-naïve metastatic urothelial carcinoma patients: An Austrian real-world analysis.
Journal: International journal of cancer
Published: May 05, 2025
Can we develop effective direct or indirect inhibitors of transcription factors? On the clinical evolution of protein degraders for multiple myeloma therapy.
Journal: Expert opinion on therapeutic targets
Published: March 23, 2025
PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism.
Journal: Molecular oncology
Published: February 24, 2025
Real-world Evidence for Enfortumab Vedotin in Patients with Metastatic Urothelial Cancer: An Austrian Multicentre Study.
Journal: Clinical genitourinary cancer
Published: October 08, 2024
Favorable impact of PD1/PD-L1 antagonists on bone remodeling: an exploratory prospective clinical study and ex vivo validation.
Journal: Journal for immunotherapy of cancer
Published: April 19, 2024
Dual therapeutic targeting of MYC and JUNB transcriptional programs for enhanced anti-myeloma activity.
Journal: Blood cancer journal
Published: April 13, 2024
Correction: Mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia: therapeutic implications.
Journal: Breast cancer research : BCR
Published: April 02, 2024
Editor's Note: Targeting Akt and Heat Shock Protein 90 Produces Synergistic Multiple Myeloma Cell Cytotoxicity in the Bone Marrow Microenvironment.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 16, 2024
Real-World Evidence of Triplet Therapy in Metastatic Hormone-Sensitive Prostate Cancer: An Austrian Multicenter Study.
Journal: Clinical genitourinary cancer
Published: October 12, 2023
Cox proportional hazards deep neural network identifies peripheral blood complete remission to be at least equivalent to morphologic complete remission in predicting outcomes of patients treated with azacitidine-A prospective cohort study by the AGMT.
Journal: American journal of hematology
Published: June 01, 2023
Last Updated: 09/26/2026